These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. GFR as the "Gold Standard": Estimated, Measured, and True. Levey AS; Inker LA Am J Kidney Dis; 2016 Jan; 67(1):9-12. PubMed ID: 26708193 [No Abstract] [Full Text] [Related]
54. Appropriate use of radiopaque contrast media to verify intracerebroventricular cannula placement in the live rat. Alguacil LF; Jiménez I; González-Mártin C; Böhle F; Martin JL Contemp Top Lab Anim Sci; 1995 Sep; 34(5):84-6. PubMed ID: 16457547 [No Abstract] [Full Text] [Related]
55. Development, chemistry, and physical properties of iopamidol and its analogues. Pitrè D; Felder E Invest Radiol; 1980; 15(6 Suppl):S301-9. PubMed ID: 7203940 [TBL] [Abstract][Full Text] [Related]
56. Radiopaque contrast media. XLVI - Preliminary studies of the metabolism of iopamidol in the dog, the rabbit and man. Pitrè D; Tirone P; Viviani G Farmaco Sci; 1980 Oct; 35(10):826-35. PubMed ID: 7450018 [TBL] [Abstract][Full Text] [Related]
57. Isomeric purity and supersaturation of iopamidol. Dawson P; Pitfield J; Skinnemoen K Br J Radiol; 1983 Oct; 56(670):711-3. PubMed ID: 6616135 [TBL] [Abstract][Full Text] [Related]
58. Advantages of non-ionic contrast media in vascular applications. Malott JC; Fodor J Radiol Technol; 1984; 56(2):95-8. PubMed ID: 6390518 [TBL] [Abstract][Full Text] [Related]
59. Radiopaque contrast media. XLVII - Determination of the optical purity of iopamidol. Felder E; Pitrè D; Grandi M Farmaco Prat; 1982 Jan; 37(1):3-8. PubMed ID: 7056374 [No Abstract] [Full Text] [Related]